Components of Endocannabinoid Signaling System Are Expressed in the Perinatal Mouse Cerebellum and Required for Its Normal Development
Open Access
- 16 March 2020
- journal article
- research article
- Published by Society for Neuroscience in eneuro
- Vol. 7 (2)
Abstract
Endocannabinoid (eCB) signaling system (ECS), encompassing cannabinoid receptors and enzymes involved in the synthesis and degradation of the endogenous cannabinoid signaling lipids, is highly expressed in the cerebellar cortex of adult humans and rodents. In addition to their well-established role in neuromodulation, eCBs have been shown to play key roles in aspects of neurodevelopment in the fore- and mid-brain, including neurogenesis, cell migration, and synapse specification. However, little is known about the role of ECS in cerebellar development. In this study, we conducted immunohistochemical characterization of ECS components through key stages of cerebellar development in mice using antibodies for 2-arachidonoylglycerol (2-AG) synthetizing and degrading enzymes and the major brain cannabinoid receptor, cannabinoid receptor 1 (CB1), in combination with cerebellar cell markers. Our results reveal a temporally, spatially, and cytologically dynamic pattern of expression. Production, receptor binding, and degradation of eCBs are tightly controlled, thus localization of eCB receptors and the complementary cannabinoid signaling machinery determines the direction, duration, and ultimately the outcome of eCB signaling. To gain insights into the role of eCB signaling in cerebellar development, we characterized gross anatomy of cerebellar midvermis in CB1 knock-out (CB1 KO) mice, as well as their performance in cerebellar-influenced motor tasks. Our results show persistent and selective anatomic and behavioral alterations in CB1 KOs. Consequently, the insights gained from this study lay down the foundation for investigating specific cellular and molecular mechanisms regulated by eCB signaling during cerebellar development.Keywords
Funding Information
- HHS | NIH | National Institute on Drug Abuse (DA044000)
This publication has 55 references indexed in Scilit:
- The CB1Cannabinoid Receptor Drives Corticospinal Motor Neuron Differentiation through the Ctip2/Satb2 Transcriptional Regulation AxisJournal of Neuroscience, 2012
- Development of Axon-Target Specificity of Ponto-Cerebellar AfferentsPLOS Biology, 2011
- Presynaptic CB1 Receptors Regulate Synaptic Plasticity at Cerebellar Parallel Fiber SynapsesJournal of Neurophysiology, 2011
- EngrailedHomeobox Genes Regulate Establishment of the Cerebellar Afferent Circuit MapJournal of Neuroscience, 2010
- Requirement of cannabinoid CB1 receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projectionsEuropean Journal of Neuroscience, 2010
- The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptorsNature Neuroscience, 2010
- Monoacylglycerol Lipase Limits the Duration of Endocannabinoid-Mediated Depolarization-Induced Suppression of Excitation in Autaptic Hippocampal NeuronsMolecular Pharmacology, 2009
- Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterningProceedings of the National Academy of Sciences, 2008
- A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-ArachidonoylglycerolChemistry & Biology, 2007
- Molecular Composition of the Endocannabinoid System at Glutamatergic SynapsesThe Journal of Neuroscience, 2006